Shopping Cart
- Remove All
- Your shopping cart is currently empty
Omodenbamab (514-G3) is a humanised monoclonal antibody (Kd = 0.0467 nM) that neutralises SpA (Staphylococcus Protein A), acting by targeting SpA on the cell wall of S. aureus, and can be used for S. aureus bloodstream infections.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $247 | In Stock | |
5 mg | $647 | In Stock | |
10 mg | $987 | In Stock |
Description | Omodenbamab (514-G3) is a humanised monoclonal antibody (Kd = 0.0467 nM) that neutralises SpA (Staphylococcus Protein A), acting by targeting SpA on the cell wall of S. aureus, and can be used for S. aureus bloodstream infections. |
In vitro | Methods: Human blood cells were treated with 10 μg/mL Omodenbamab and incubated for 30 minutes, 1.5 hours, and 2.5 hours to evaluate its effect on the opsonophagocytic activity against S. aureus. Results: Omodenbamab significantly enhanced the opsonophagocytic activity of human blood cells against S. aureus. [1] |
In vivo | Methods: In a Balb/C mouse model of MRSA bacteremia, Omodenbamab was administered via intravenous injection at doses of 2.5 mg/mouse and 10 mg/mouse. Results: Omodenbamab increased survival in Balb/C mice within the MRSA bacteremia model. [1] |
Cas No. | 2241724-48-9 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.